Toshiba’s New Large-scale Production Technology for Electrolysis Electrodes for Hydrogen Production from Renewables Cuts Iridium Use to 1/10
Promoting PEM water electrolyzers for power to gas technology that will contribute to realization of…
Month: October 2022
Leeward Renewable Energy Begins Construction of Oak Trail Solar Project in North Carolina
Facility to generate 100 megawatts of renewable energy for Verizon Communications Expands LRE’s renewable energy…
Strategy Analytics: Electric Vehicle Powertrain Sensor Opportunity to Reach Billions of Dollars
Battery Electric Vehicles will be the catalyst for growth BOSTON–(BUSINESS WIRE)–The push to electric vehicles…
Baptist Health and LeanTaaS’ Collaboration in Improving Operating Room Utilization Included in 2022 Gartner® Case Study
Baptist Health increased its operating room prime time utilization by 16% across the health system…
Procurant Digitizes Produce Inspections at Merchants Distributors Inc.
Mobile solution simplifies inspections and provides real-time data to buyers, sellers of fresh produce WATSONVILLE,…
e-Zinc CEO James Larsen Named to Canada’s 2023 Clean50
Larsen honored for his commitment to advance sustainability and reduce carbon emissions in Canada TORONTO–(BUSINESS…
Global Security Appliances Market Report to 2030 – Featuring Cisco Systems, Check Point Software Technologies, Symantec and Intel Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Security Appliances Market By Deployment, By Industry Vertical, By Type: Global Opportunity Analysis…
GTM Adds Two Managing Directors as Firm Invests in Growth
Investment reflects strong demand for International Tax and Tax Automation Services WAYNE, Pa.–(BUSINESS WIRE)–Global Tax…
Siemens Government Technologies Names Katy Nierman as Chief Financial Officer
RESTON, Va.–(BUSINESS WIRE)–Siemens Government Technologies (SGT) today announced that Katy Nierman has been appointed its…
IoT Integration in B2B: Challenges
By Edmund Gair, Head of Operations & Strategy, Viatick The internet of things, or IoT,…
Sorrento Therapeutics to Participate in Key Opinion Leader Panel Discussion on “New Horizons for the Treatment of Non-small Cell Lung Cancer”
Panel to Discuss Unmet Need in Non-small Cell Lung Cancer and the Potential for Abivertinib,…
Capricor Therapeutics to Present One-Year Results from HOPE-2 Open Label Extension Study at World Muscle Society 2022
SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company…
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods Embodied by the Pure-Vu® System
Patent provides additional intellectual property protection for methods to enable high-quality colonoscopy with no or…
Bespoke Extracts, Inc. Receives Regulatory Approval from Colorado Marijuana Enforcement Division
Approval qualifies Bespoke to acquire licensed cannabis operations throughout Colorado Denver, CO, Oct. 06, 2022…
Hillstream BioPharma, Inc. to Present at Upcoming Investor Conferences
BRIDGEWATER, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or…
Homology Medicines to Participate at Upcoming Conferences
BEDFORD, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage…
Lisata Therapeutics Announces Participation in Upcoming Conferences in October 2022
BASKING RIDGE, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
Acer Therapeutics Announces University of North Carolina Receives Department of Defense Grant to Support the Proposed Investigator Sponsored OASIS Trial of ACER-801 (Osanetant) to Reduce the Frequency and Severity of Post-Traumatic Stress Disorder
$3 million awarded to University of North Carolina (UNC) to support a proposed 180-patient, randomized,…
Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy
Professor Swanton joins Achilles SAB member Dr. Christopher Klebanoff and Dr. John Haanen on the…
Mustang Bio Announces First Patient Treated in Its Multicenter Phase 1/2 Clinical Trial of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy to Treat B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Enrollment continues in clinical trial of MB-106 under Mustang’s IND; next data disclosure anticipated 4Q…